Congress risks long-term damage to the FDA
BioCentury,
All members of the biopharma industry should call on Congress to reauthorize FDA user fees this month, before their expiration…
All members of the biopharma industry should call on Congress to reauthorize FDA user fees this month, before their expiration…
A new analysis conducted by Friends of Cancer Research ( Friends ) published today in Clinical Cancer Research, a journal of…